Insider · CIK 0001225503

CARTER BRUCE L A

Reports to the SEC for 8 companies · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001225503

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-11	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2025-03-13	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2024-03-06	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+15.7K sh	—	—	15,700
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,021 sh	—	—	11,252
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−6,808 sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−7,520 sh	—	—	0
2024-01-23	Mirati Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−4,444 sh	—	—	6,808
2023-12-29	Mirati Therapeutics, Inc.A Award	Director	AAward	+6,808 sh	$58.75	+$400K	17,273
2023-03-02	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,800
2023-01-20	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+7,520 sh	—	—	7,520
2023-01-20	Mirati Therapeutics, Inc.A Award	Director	AAward	+4,444 sh	—	—	10,465
2022-08-12	Mirati Therapeutics, Inc.S Sale	Director	SSale	−5,107 sh	$85.04	−$434K	10,914
2022-08-12	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2022-08-12	Mirati Therapeutics, Inc.S Sale	Director	SSale	−4,893 sh	$85.96	−$421K	6,021
2022-08-12	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$27.00	+$270K	16,021
2022-03-21	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−2,676 sh	$66.70	−$178K	3,324
2022-03-21	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−307 sh	$67.23	−$20.6K	3,017
2022-03-21	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−807 sh	$69.52	−$56.1K	0
2022-03-21	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$25.58	+$153K	6,000
2022-03-21	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−2,210 sh	$68.66	−$152K	807
2022-03-21	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	0
2022-03-03	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2022-01-14	Mirati Therapeutics, Inc.A Award	Director	AAward	+2,546 sh	—	—	6,021
2022-01-14	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+3,688 sh	—	—	3,688
2021-04-05	Mirati Therapeutics, Inc.S Sale	Director	SSale	−282 sh	$180.00	−$50.8K	3,475
2021-04-05	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,250 sh	—	—	0
2021-04-05	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,250 sh	$6.78	+$15.3K	5,725
2021-04-05	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,968 sh	$176.70	−$348K	3,757
2021-03-02	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2021-02-02	Mirati Therapeutics, Inc.S Sale	Director	SSale	−218 sh	$194.38	−$42.4K	3,475
2021-02-02	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,250 sh	$6.78	+$15.3K	5,725
2021-02-02	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,732 sh	$190.50	−$330K	3,993
2021-02-02	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,250 sh	—	—	2,250
2021-02-02	Mirati Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$192.31	−$57.7K	3,693
2021-01-15	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)A Award	Director	AAward	+2,155 sh	—	—	2,155
2021-01-15	Mirati Therapeutics, Inc.A Award	Director	AAward	+1,475 sh	—	—	3,475
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1 sh	$248.96	−$248.955	2,000
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−357 sh	$248.28	−$88.6K	2,001
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−710 sh	$247.63	−$176K	2,358
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−257 sh	$246.27	−$63.3K	3,068
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−589 sh	$244.97	−$144K	3,325
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−287 sh	$244.05	−$70K	3,914
2020-12-14	Mirati Therapeutics, Inc.S Sale	Director	SSale	−49 sh	$240.93	−$11.8K	4,201
2020-12-14	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,250 sh	—	—	4,500
2020-12-14	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,250 sh	$6.78	+$15.3K	4,250
2020-08-11	Mirati Therapeutics, Inc.Non Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,250 sh	—	—	6,750
2020-08-11	Mirati Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,250 sh	$6.78	+$15.3K	4,250
2020-08-11	Mirati Therapeutics, Inc.S Sale	Director	SSale	−1,300 sh	$125.78	−$164K	2,950

Recent filings

Accepted (ET)
Mar 134
CARTER BRUCE L A0002064832-26-000138
SEC(opens sec.gov)
Mar 144
CARTER BRUCE L A0001062993-25-005502
SEC(opens sec.gov)
Mar 84
CARTER BRUCE L A0001062993-24-006036
SEC(opens sec.gov)
Jan 234
CARTER BRUCE L A0001140361-24-003535
SEC(opens sec.gov)
Jan 34
CARTER BRUCE L A0001628280-24-000292
SEC(opens sec.gov)
Mar 64
CARTER BRUCE L A0001062993-23-006087
SEC(opens sec.gov)
Jan 244
CARTER BRUCE L A0001214659-23-001041
SEC(opens sec.gov)
Aug 164
CARTER BRUCE L A0001214659-22-010296
SEC(opens sec.gov)
Mar 224
CARTER BRUCE L A0001062993-22-008344
SEC(opens sec.gov)

Companies

Address

C/O ENANTA PHARMACEUTICALS, INC. 4 KINGSBURY AVENUE

WATERTOWN, MA, 02472